Results 101 to 110 of about 7,902 (191)

Effect of olmesartan on oxidative stress in hemodialysis patients. [PDF]

open access: yes
The effect of olmesartan, an inverse angiotensin II type 1 receptor blocker (ARB), on oxidative stress in hemodialysis (HD) patients is not fully understood, and has not been widely investigated in vitro or in vivo.
45138   +26 more
core  

Olmesartan-associated enteropathy: results of a national survey

open access: yes, 2014
BACKGROUND: Recently, a new enteropathy has been described: olmesartan-associated enteropathy. However, the association has been questioned: a phase 3 trial and a cohort study found no association between gastrointestinal events and olmesartan.
Marthey, L.   +49 more
core   +1 more source

Olmesartan, an AT1 Antagonist, Attenuates Oxidative Stress, Endoplasmic Reticulum Stress and Cardiac Inflammatory Mediators in Rats with Heart Failure Induced by Experimental Autoimmune Myocarditis

open access: yesInternational Journal of Biological Sciences, 2011
Studies have demonstrated that angiotensin II has been involved in immune and inflammatory responses which might contribute to the pathogenesis of immune-mediated diseases.
Vijayakumar Sukumaran, Kenichi Watanabe, Punniyakoti T. Veeraveedu, Narasimman Gurusamy, Meilei Ma, Rajarajan A. Thandavarayan, Arun Prasath Lakshmanan, Ken'ichi Yamaguchi, Kenji Suzuki, Makoto Kodama
doaj  

Blocker, angiotensin II receptor olmesartan to interrupt cardiovascular continuum: vesselsand cardioprotective, anti-atherosclerotic and metabolic pleiotropic effects (part 2)

open access: yesКардиоСоматика, 2015
The article provides an overview of pleiotropic activity and clinical efficacy of one of the representatives of the class of angiotensin receptor blockers II - olmesartan medoxomil.
M. G Bubnova
doaj  

Radioiodination of olmesartan medoxomil and biological evaluation of the product as a tracer for cardiac imaging

open access: yes, 2017
The present study is oriented to synthesis of radioiodinated olmesartan medoxomil (OM) for potential cardiac imaging. Olmesartan medoxomil has been labeled with [125/131I] using chloramine-T (Ch-T) as an oxidizing agent. The key effective factors such as
Safaa B. Challan   +2 more
core   +1 more source

ROLE OF BLOOD PRESSURE REDUCTION IN PREVENTION OF CARDIAC AND VASCULAR HYPERTROPHY

open access: yesРоссийский кардиологический журнал, 2011
We investigated whether prevention of cardiac and vascular remodelling associated with inhibition of angiotensin II is independent of the blood pressure (BP) lowering action of angiotensin II type 1 (AT1) receptor blockade.
H. Yokoyama   +5 more
doaj  

Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines

open access: yes, 2015
Stefano Omboni,1 Ettore Malacco,2 Jean-Michel Mallion,3 Massimo Volpe4,5 1Clinical Research Unit, Italian Institute of Telemedicine, Solbiate Arno, Varese, Italy; 2Department of Internal Medicine, Ospedale L Sacco, University of Milan, Milan, Italy ...
Omboni S, Malacco E, Volpe M, Mallion JM
core  

Olmesartan downregulates CARP and ameliorates cardiomyocyte hypertrophy.

open access: yes, 2014
(A) Treatment with RNH6270 (RNH 1 µM, active form of olmesartan) reduced Ang II (1 µM) -induced increased of CARP protein in NRVCs ...
Xiaobo Huang (608424)   +11 more
core   +1 more source

Il ruolo della associazione precostituita Olmesartan/Amlodipina

open access: yes, 2016
Profilo farmacologico e razionale di impiego della associazione precostituita Olmesartan/Amlodipina nella terapia della ipertensione arteriosa, nel paziente iperteso diabetico e nel paziente iperteso ...
Genovese, S., BORGHI, CLAUDIO
core  

Home - About - Disclaimer - Privacy